增强型体外反搏在高血压患者中的应用及进展

Application and Progress of Enhanced External Counterpulsation in Patients with Hypertension

摘要: 我国人群高血压的患病率仍呈升高趋势。血压水平与心脑血管病发病和死亡风险之间存在密切的因果关系。目前可以选择的治疗方案主要有生活方式干预、药物治疗及相关危险因素的处理。增强型体外反搏(EECP)作为一种无创的机械辅助循环装置，现广泛应用于心脑血管病以及各种不同病因所致的循环障碍。现有文献证实EECP对高血压患者疗效显著，本文就EECP治疗高血压的临床进展进行综述。

Abstract: The prevalence of hypertension in China is still increasing. There is a close causal relationship between blood pressure levels and the risk of cardiovascular and cerebrovascular disease morbidity and mortality. At present, the main treatment options are lifestyle intervention, drug therapy, and management of related risk factors. As a non-invasive mechanically assisted circulatory device, enhanced external counterpulsation (EECP) is widely used in cardiovascular and cerebrovascular diseases and circulatory disorders caused by various etiologies. The existing literature confirms that EECP has significant efficacy in patients with hypertension, and this article reviews the clinical progress of EECP in the treatment of hypertension.